Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy

NCT05023889 is registered in ClinicalTrials.gov with Austin Neuromuscular Center as lead sponsor.

NCT NCT05023889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05023889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy
Lead sponsor
Austin Neuromuscular Center
Phase
Phase 1
Overall status
Completed
Start date
August 3, 2022
Completion date
April 13, 2026
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polyneuropathies, transthyretin amyloidosis, wild type attr amyloidosis, wild-type transthyretin cardiac amyloidosis, wild-type transthyretin-related (attr)amyloidosis